NASDAQLPCN
Year
View
Form | Description | Date | Format |
---|---|---|---|
3 | Initial filing by director officer or owner of more than ten percent. | Feb 14, 2012 | ![]() ![]() ![]() ![]() |
We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.
Form | Description | Date | Format |
---|---|---|---|
3 | Initial filing by director officer or owner of more than ten percent. | Feb 14, 2012 | ![]() ![]() ![]() ![]() |